These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 6346866)

  • 1. The dilemmas of patient treatment for end-stage renal disease.
    Schmidt RW; Blumenkrantz M; Wiegmann TB
    Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effective care of end-stage renal disease: a billion dollar question.
    Roberts SD; Maxwell DR; Gross TL
    Ann Intern Med; 1980 Feb; 92(2 Pt 1):243-8. PubMed ID: 6766290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home dialysis and dialysis treatment modalities in the VA system.
    Wiegmann TB; Blumenkrantz M; Layard M; Schmidt RW; Shen F; Stead W
    Am J Kidney Dis; 1983 Jul; 3(1):32-6. PubMed ID: 6346865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
    Hörl WH; de Alvaro F; Williams PF
    Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost of dialysis in France].
    Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
    Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of renal dialysis in a UK setting--a multicentre study.
    Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K
    Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching and the definition of modality in end-stage renal disease treatment.
    Smith DG; Wheeler JR
    Med Care; 1987 Dec; 25(12):1168-78. PubMed ID: 3320593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of Dialysis Therapy by Modality in Manitoba.
    Beaudry A; Ferguson TW; Rigatto C; Tangri N; Dumanski S; Komenda P
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1197-1203. PubMed ID: 30021819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance dialysis population dynamics: current trends and long-term implications.
    Lysaght MJ
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S37-40. PubMed ID: 11792760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of renal replacement therapies in Finland.
    Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
    Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.
    McFarlane PA
    Semin Dial; 2004; 17(2):118-24. PubMed ID: 15043613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing VA and private sector healthcare costs for end-stage renal disease.
    Hynes DM; Stroupe KT; Fischer MJ; Reda DJ; Manning W; Browning MM; Huo Z; Saban K; Kaufman JS;
    Med Care; 2012 Feb; 50(2):161-70. PubMed ID: 21945972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-mix and treatment in end-stage renal disease: hemodialysis v peritoneal dialysis.
    Radecki SE; Mendenhall RC; Nissenson AR; Freeman RB; Blagg CR; Capelli JP; Gentile DE; Feinstein EI
    Am J Kidney Dis; 1988 Jan; 11(1):7-14. PubMed ID: 3122560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.